Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Xavier Badía(Oblikue Consulting (Spain)), César Hernández(Agencia Española de Medicamentos y Productos Sanitarios)
Cited by 9
Related Papers
A comparison of EQ-5D time trade-off values obtained in Germany, The United Kingdom and Spain
|Unknown|2003|37
Validación del cuestionario de satisfacción con el tratamiento antirretroviral: cuestionario CESTA
|Enfermedades Infecciosas y Microbiología Clínica|2005|11